Opus Genetics (IRD) Change in Acquisitions & Divestments (2011 - 2020)

Opus Genetics (IRD) has 8 years of Change in Acquisitions & Divestments data on file, last reported at $3.0 million in Q1 2020.

• On a quarterly basis, Change in Acquisitions & Divestments changed 0.0% year-over-year to $3.0 million in Q1 2020; TTM through Sep 2020 was $6.0 million, a 45.45% decrease from a year earlier, with the FY2019 full-year figure at $12.0 million, changed 0.42% from the prior year.
• Change in Acquisitions & Divestments for Q1 2020 stood at $3.0 million, roughly flat from $3.0 million in the prior quarter.
• Over the last five years, Change in Acquisitions & Divestments for IRD reached as high as $5.1 million in Q3 2016 and fell as low as $960000.0 in Q1 2016.
• Historically, Change in Acquisitions & Divestments has averaged $3.1 million across 5 years, with a median of $3.0 million in 2017.
• Across the five-year window, Change in Acquisitions & Divestments tumbled 80.74% in 2016 and jumped 183.33% in 2017, its largest moves.
• Year by year, Change in Acquisitions & Divestments stood at $4.7 million in 2016, then tumbled by 35.9% to $3.0 million in 2017, then plunged by 33.33% to $2.0 million in 2018, then soared by 50.0% to $3.0 million in 2019, then changed by 0.0% to $3.0 million in 2020.
• Per Business Quant data, the three most recent Change in Acquisitions & Divestments figures were $3.0 million in Q1 2020, $3.0 million in Q4 2019, and $3.0 million in Q3 2019.